ロード中...
The Acetylcholine-Activated Potassium Current Inhibitor XAF-1407 Terminates Persistent Atrial Fibrillation in Goats
Aims: The acetylcholine-activated inward rectifier potassium current (I(KACh)) has been proposed as an atrial-selective target for the treatment of atrial fibrillation (AF). Using a novel selective I(KACh) inhibitor XAF-1407, the study investigates the effect of I(KACh) inhibition in goats with paci...
保存先:
| 出版年: | Front Pharmacol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7873360/ https://ncbi.nlm.nih.gov/pubmed/33584287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.608410 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|